Coelho_indictment_0.pdf Apr 2026

Former Pfizer statistical programming lead Bruno Coelho was indicted in early 2024 for an alleged insider trading scheme involving confidential Paxlovid clinical trial data. Coelho allegedly generated over $215,000 in profits by purchasing Pfizer call options after accessing non-public, high-effectiveness data, leading to charges of securities and wire fraud in the Southern District of New York.